Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639418 · ClinicalTrials.gov registry record
A Study to Describe Pediatric Influenza Vaccine Coverage
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 147,494
- Enrollment target
NCT00639418: Completed study, sponsored by MedImmune.
NCT00639418 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 147,494 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639418 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 147,494 participants
- Enrollment target
Study Summary
The purpose of this study is to describe flu vaccine coverage in children under 18 years of age and to examine correlations between in-office flu vaccine coverage and the use of various tactics to increase vaccine coverage.
Primary Outcome
Vaccine coverage was calculated from the number of participants vaccinated in each group, divided by the total number of participants under the practice's care in that specific age group.
Interventions
- BIOLOGICAL Influenza vaccination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147,494 participants |
| Start Date | 2007-08 |
| Est. Completion | 2011-06 |
What the finished NCT00639418 record still lists
NCT00639418 is an observational study that tracks outcomes without assigning an intervention. Its 147,494 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccination is the first listed.
NCT00639418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00639418 about?
NCT00639418 is a clinical study titled "A Study to Describe Pediatric Influenza Vaccine Coverage". The purpose of this study is to describe flu vaccine coverage in children under 18 years of age and to examine correlations between in-office flu vaccine coverage and the use of various tactics to increase vaccine coverage.
What is the current status of trial NCT00639418?
This trial is currently completed. The enrollment target is 147,494 participants. The study started on 2007-08. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00639418?
The interventions under investigation include: Influenza vaccination (BIOLOGICAL).
Who is sponsoring clinical trial NCT00639418?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia